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Dnmt3aa b s t r a c t
MicroRNAs (miRNAs) are small non-coding RNAs that participate in a large variety of biological pro-
cesses. In this paper, the spatiotemporal expression pattern of miR-370 was characterized during
mouse embryonic development, and was found to be stage- and tissue-speciﬁcally expressed. In
addition, through luciferase reporter assays and western blot analyses, DNA methyltransferase 3A
(Dnmt3a) was identiﬁed as a directly regulated target of miR-370. Altogether, our results indicate
that miR-370 may play important roles in the morphogenesis of diverse organs, especially brain
and adrenal glands, by mediating Dnmt3a expression during mouse development.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
miRNAs are a novel class of small, single-stranded, and highly
conserved non-coding RNAs whose genes may either give rise to
single miRNA or exist in a transcriptional unit as miRNA clusters
[1]. miRNAs posttranscriptionally repress gene expression by rec-
ognizing complementary seeds in the 30untranslated region
(30UTR) of target mRNAs [2,3]. They have already been demon-
strated to be involved in a large variety of biological processes,
including cell cycle progression, apoptosis, differentiation, repro-
gramming into induced pluripotent stem cells (iPSCs), hematopoi-
esis [4–9], development [10], and metabolism [11]. However,
microRNAs’ roles in pre-implantation and post-implantation em-
bryo development are controversial. In Caenorhabditis elegans, Di-
cer functions in RNA interference and in the synthesis of small
RNA involved in developmental timing [12]. miR-34 modulates
ageing and neurodegeneration in Drosophila[13]. miR-126a and
miR-126b were found to synergistically regulate zebraﬁsh vascular
integrity, and pak1 is a critical target of miR-126a/b in vascular
development [14]. Moreover, miRNA might be suppressed in oo-
cytes [15,16]. These data, together with functional studies in C. ele-
gans, Drosophila and ﬁsh [17], support the belief that miRNAs are
critical in key developmental events in vertebrates and inverte-
brates [18].
In mice, miR-370 is located on chromosome 12 (12qF1), while
its human homologue, has-mir-370, is located on human chromo-some 14 (14q32). It is highly conserved in the Dlk1-Dio3 cluster,
which is downstream of Gtl2. miR-370 is a paternally imprinted
gene as well as its host gene Rian[19], and is regulated by the dif-
ferentially methylated region (IG-DMR) 200 kb upstream of the
miRNA cluster [20]. Previous evidence indicates that miR-370
could not be detected in mouse embryonic stem (mES), maybe
they expressed only at very low levels [21]. Another study, focused
on ischemic preconditioning following ischemia and reperfusion
injury, discovered that miR-370 positively correlated with injury
severity [22]. In addition, some diabetes researchers found that
miR-122 expression can be controlled by miR-370 in the setting
of lipid metabolism [23].
However, miRNA involvement in the regulation of develop-
ment, especially the morphogenesis of diverse organs, has not been
well documented. miR-370 has been noted to be differentially ex-
pressed in some cancers, such as colorectal cancer [24], gastroin-
testinal stromal tumors [25], and AML [26]. With the exception
of TGFb-RII[27], MAP3K8[28], FoxM1[26] and Cpt1a[23], miR-370
target genes in these cancers remain unknown. DNA methyltrans-
ferase 3a (Dnmt3a) is responsible for the de novo methylation of
DNA during embryonic development, which results in transcrip-
tional silencing [29]. Previous studies have shown that Dnmt3a
and Dnmt3b are crucial for gene imprinting, embryonic develop-
ment and growth [30]. Interestingly, miR-370 expression can be
detected in association with imprint erasure [31]. Of note,
DNMT3A has been found to be signiﬁcantly up-regulated in many
cancers [32].
In short, little is known about the functional consequences of
miR-370 during mouse development and even less in tumorigene-
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situ hybridization and quantitative real-time RT-PCR (qRT-PCR)
during mouse development. We found that miR-370 is a stage-
and tissue-speciﬁc miRNA. Furthermore, Dnmt3a was identiﬁed
as a miR-370 target gene that may be mediated in the process of
mouse embryonic generation.
2. Materials and methods
2.1. Animals and embyros
ICR mice were purchased from SIPPR-BK Experimental Animal
(Shanghai, China). ICR female mice aged 6–8 weeks were superov-
ulated by consecutive injections of 10 IU of pregnant mare serum
gonadotropin (PMSG) and 10 IU of human chorionic gonadotropin
(hCG) 48 h apart. Unfertilized eggs were harvested from females at
20 h post-hCG injection without mating. Embryos at the 2-cell, 4-
cell, 8-cell, 16-cell, and morulae stages were ﬂushed out from the
oviducts at 40–42, 54–56, 62–64, 69–71 and 76–78 h after hCG
injection. Blastocysts were retrieved from the uterine horns at
86–88 h post-hCG injection. Embryos were isolated at different
developmental stages and ﬁxed in 4% paraformaldehyde-PBS at
4 C overnight. Embryos were parafﬁn embedded and sectioned
at 9 lm. All animal experiments were undertaken in accordance
with the National Institute of Health’s guide for the care and use
of laboratory animals.
2.2. RNA isolation and TaqMan real-time PCR
For miRNA expression analysis, embryos at different develop-
mental stages were pooled for RNA extraction. Reverse transcrip-
tion was performed using the TaqMan H MicroRNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA, USA). Micr-
oRNA expression was determined with the TaqMan MicroRNA as-
say (Applied Biosystems) according to the manufacturer’s protocol
on the Applied Biosystems 7500 Detection system (Applied Biosys-
tems). All experiments were performed in triplicate. Data were
normalized to the expression of small nuclear RNA (snRNA) U6
and expressed as relative expression (2DCt).
2.3. MicroRNA in situ hybridization
In situ hybridization (ISH) for microRNA detection was per-
formed with locked nucleic acid (LNA) probes according to previ-
ously published methods [33]. The miR-370 LNA probe (Exiqon)
was labeled using the DIG-30-end labeling kit (Roche, Mannheim,
Germany). Antisense LNA probe for miR-370, with sequence ACC
AGG TTC CAC CCC AGC AGG C, was ordered from Exiqon (http://
Exiqon.com).
2.4. Cell culture and transfection
Non-tumor cell lines (NIH3T3, TM3 and Y1) and colon cancer
cell lines (AtT20, MS5, CaCO2, N2A, Hepa1–6, B16, EL4, F9, LLC,
MFC, MLTC-1) (American Type Culture Collection, USA) were cul-
tured at 37 C in a 5% CO2 atmosphere. They were maintained in
either Dulbecco’s modiﬁed Eagle’s medium (DMEM) or RPMI-
1640 medium supplemented with 10% fetal bovine serum (Gibco)
and 2 mM L-glutamine.
An enforced expression of miR-370 expression in colon cancer
cells was achieved by transfection with miR-370-expressing pSi-
lencer 4.1-CMV neo vector. A fragment of 459 bp corresponding
to miR-370 and the surrounding sequences was ampliﬁed from
mouse genomic DNA using the following primers: sense: 50-TGT
CTC GGC CAA GGT CAG-30 and antisense: 50-AGC CCT CCC ACAGCA ACT-30. The miR-370 inhibitor and negative control were syn-
thesized by GenePharma (http://www.genepharma.com). Cells
were transfected with 40 nM precursor with Lipofectamine 2000
(Invitrogen, Eugene, USA). Total RNA were prepared 24 h later
while protein was harvested 48 h after transfection and used for
qRT-PCR or Western blot analysis, respectively.
2.5. Luciferase assay
The precursor to miR-370 was synthesized and cloned in pSilen-
cer. By using bioinformatic tools for miRNA target prediction, such
as PicTar (http://pictar.bio.nyu.edu/), Targetscan (http://www.tar-
getscan.org), and miRanada (http://www.microrna.org), we identi-
ﬁed several potential binding regions for miR-370 in Dnmt3a and
Dnmt3b. Fireﬂy luciferase reporter vectors with or without the in-
tact putative miR-370 recognition sequence from the 30-UTR of
Dnmt3a (primer sense: 50-CCG TCA GTT CCG CTT CAT C30, anti-
sense: 50-CTC CCT ATC CAA CCG TCC A-30) were constructed by
pMIR-REPORT™ miRNA Expression Reporter Vector (Applied Bio-
systems). All constructs were conﬁrmed by sequencing. For the
30UTR-luciferase assays, cells were co-transfected with 0.15 lg
pMIR-REPORT or no-30-UTR construct, 0.4 lg of pSilencerNC or pSi-
lencer-miR and 0.015 lg pRL-TK Renilla luciferase expression con-
struct using Lipofectamine 2000. Luciferase assays were performed
24 h after transfection using the Dual Luciferase Reporter Assay
system (Promega, Madison, USA). Relative luciferase activity was
normalized with Renilla luciferase activity.
2.6. Western blot analysis
Protein extracts were prepared with RIPA lysis buffer in the
presence of proteinase inhibitors. Western blot analysis was per-
formed according to standard protocols. Antibodies against the
Dnmt3a (CST, Boston, USA) and b-Tublin (Abcam, Cambridge, UK)
were used in accordance with the manufacturer’s instructions.
The signals were detected using a chemiluminescence detection
kit (GE, USA).
2.7. Statistical analysis
All experiments were repeated at least three times, and the data
were expressed as the mean ± SEM. The Student’s t-test was used
for statistical comparisons. P values less than 0.05 were considered
statistically signiﬁcant.
3. Results
3.1. The location and conservation analysis of the miR-370 gene
TheMus musculusmiR-370 gene (Gene ID: 723854) is located in
the third intron of Rian (Gene ID: 7574), downstream of Meg3
(Gene ID: 17263) on mouse chromosome 12 (Fig. 1A). We analyzed
the third intron of Rian by CpG Island Searcher (http://cpgis-
lands.usc.edu) and found that miR-370 was harbored within a pre-
dicted CpG island (Fig. 1A). To clarify that miR-370 is
phylogenetically conserved, multiple nucleotide sequence align-
ment comparisons were generated by DNAMAN. The results dem-
onstrate that mature miR-370 is 100% conserved in mammals
(Fig. 1B).
3.2. Expression of miR-370 in pre-implantation embryos by qRT-PCR
Using the TaqMan MicroRNA assay, miR-370 was barely
detected in all pre-implantation embryos before E6.5 (Fig. 2A).
However, its expression level was relatively higher in the
Fig. 1. Location of mmu-miR-370. (A) Annotation of theM. musculusmiR-370 gene (Gene ID: 723854). Host and downstream genes are indicated, as is a predicted CpG island.
(B) Comparison of miR-370 orthologs was generated by multiple nucleotide sequence alignment. Regions exhibiting 100% conservation in mammals are underlined.
Fig. 2. miR-370 expression proﬁle at different developmental stages. Quantitative
RT-PCR was used to analyze miR-370 expression in (A) pre-implantation embryos
and (B) post-implantation embryos. The quantity of miR-370 was normalized to U6
RNA expression. Different developmental stages were denoted as oocytes (Oo), 2-
cell (2C), 4-cell (4C), 8-cell (8C), 16-cell (16C), morula (M) and blastocyst (B). E:
Embryo day.
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stage, and then decreased during the mid-later embryonic stages
of E9.5–E18.5 (Fig. 2B).
3.3. Expression analysis of miR-370 by in situ hybridization
miR-370 was ﬁrst detected by whole mount in situ hybridiza-
tion (WISH) at E9.5–E11.5 (Fig. 3). Strong express signals were ac-
quired in the cortical anlage of the telencephalon vesicle, alar plateof midbrain and nervous plate of rhombencephalon. The dorsal
view of the same embryo showed that the major signals were
along the dorsal midline from the mid-hindbrain region through
neural tube to spinal cord. In addition, signals existed at the otic
vesicle, forelimb and tail. As a negative control, no signals were
detected using the sense probe (data not shown).
Sagittal sections of complete mouse embryos at E15.5 showed
relatively ubiquitous expression of miR-370 (Fig. 4A). Abundant
expression was detected in most parts of the brain, adrenal gland
(Fig. 4J), tongue, dorsal root ganglia, muscles, and some bone pri-
mordium. Signals were clearly observed in the olfactory bulb, fore-
brain, cerebral cortex, cerebellar, and pituitary, but were barely
detected in the medulla oblongata. miR-370 was also highly ex-
pressed in the olfactory epithelium and vibrissae follicle.
We further investigated the expression of miR-370 among di-
verse tissues at E15.5 using qRT-PCR. Results showed that expres-
sion of miR-370 was most abundant in tongue, brain and adrenal
gland, moderate in lung and liver (Fig. 5), and lowest in heart
and kidney (Fig. 5).
3.4. miR-370 directly targets Dnmt3a
Dnmt3a was deﬁned as a potential target of miR-370 by bioin-
formatic analysis on the basis of putative binding sites (Fig. 6A).
Next, we detected miR-370 and Dnmt3a expression patterns in
various cell lines. miR-370 expression was low in mouse cell lines
with the exception of AtT20, F9 and MLTC-1 (Sup. Fig. 1). We se-
lected NIH3T3 and AtT20 cells that have low and high endogenous
expression of miR-370, respectively (Fig. 6B), for further experi-
mentation. Of note, as shown in Sup. Fig. 2A, relatively high expres-
sion was obtained from pSilencer-miR-370 transfection that could
be suppressed by almost 80% with a speciﬁc inhibitor. Using these
cell lines, we conﬁrmed that forced-expression of miR-370 inhib-
ited Dnmt3a in NIH3T3 cells. Brieﬂy, over-expression of miR-370
in NIH3T3 decreased Dnmt3a-driven luciferase activity by approx-
imately 65.3% when compared with control (Fig. 6C, lanes 1–3). On
the other hand, transfection of the miR-370 inhibitor into AtT20s
suppressed the function of endogenous miR-370, in association
with signiﬁcantly increased (75.3%) Dnmt3a-luciferase activity
when compared with the scramble control (Fig. 6D). To further
conﬁrm that Dnmt3a is a direct target of miR-370, rescue
Fig. 3. Whole mount in situ hybridization (WISH) analyses of the expression of miR-370 at E9.5–E11.5. (B, E, and H) Lateral, (A, D and G) ventral and (C, F and I) dorsal views
are shown. Key structural features are indicated. Telencephalon vesicle (tb), midbrain (mb), rhombencephalon (rh), neural tube (nt), spinal cord (sc), otic vesicle (ov), forelimb
(ﬂ) and tail (ta).
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either miR-370 inhibitor or scramble control with the Dnmt3a
luciferase reporter gene system. As shown in Fig. 6C (lanes 4–5),
inhibition of ectopic miR-370 increased luciferase activity up to
136.8%. Using similar conditions, western blot analysis was per-
formed to detect Dnmt3a protein expression. Similar results were
achieved in the over-expression and rescue experiments (Fig. 6E
and F), whereby over-expression of miR-370 decreased Dnmt3a
protein levels, and this suppression was rescued by the miR-370
anti-strand inhibitor (Fig. 6F).
4. Discussion
Embryonic development is a complex and tightly regulated pro-
cess. miRNAs are indispensable regulators that ﬁne-tune the
expression of many genes simultaneously. They have been shown
to be important in early embryo development of C. elegans [34],
Drosophila [35], ﬁsh [17] and mammals [36]. Mature miR-370 is
100% conserved in mammals, thus it provides an opportunity to
study its role in conserved regulatory networks across species.
Mouse pre-implantation embryos express developmental
stage-speciﬁc miRNAs. However, a previous study suggested that
miR-370 might be expressed at such a low level that it cannot bedetected in mES cells [21]. Here, we demonstrated that miR-370
is a stage- and tissue-speciﬁcally expressed miRNA in implantation
embryos. Our results suggest it may play important roles in the
morphogenesis of diverse organs, especially the brain and adrenal
glands, where miR-370 was highly expressed. Signals in many
bone primordia such as the pillow bottom bone, Gergen Bauer’s
cells, temporal bone and skull primordium suggest that miR-370
may be an important regulator in chondrocyte generation. Notably,
miR-370 was readily detected in the olfactory bulb, olfactory epi-
thelium, optic recess, vibrissae follicle, otic vesicle, tongue, cerebral
cortex, cerebellum and dorsal root ganglia, suggesting that miR-
370 might be relevant to the regulation of sensory formation, such
as vision, hearing, smell, taste and touch.
Dnmt3a, a key enzyme involved in DNA methylation, is respon-
sible for the de novo methylation of DNA during embryonic devel-
opment and subsequent transcriptional silencing [29]. Previous
studies have shown that Dnmt3a and Dnmt3b have crucial roles
in gene imprinting, embryonic development and growth [30].
Interestingly, miR-370 expression can be detected in association
with imprint erasure [31], simultaneously with changes to the
DNA methylation proﬁle. Methylation changes to the genome are
controlled by DNA methyltransferases (DNMTs). At present, three
catalytically active DNMTs, DNMT1, DNMT3A, and DNMT3B, have
Fig. 4. miR-370 expression pattern at E15.5. E15.5 embryos were sectioned and miR-370 expression was examined by in situ hybridization. (A) Sagittal sections of complete
mouse embryos at E15.5 showed abundant expression of miR-370. Under 100 magniﬁcation, signals clearly observed in speciﬁc parts of the brain (B, D) including the
olfactory bulb (ob), forebrain (fb), cerebral cortex (cx) (A), cerebellar (ce) (C), pituitary (pi) (I), but was barely detectable in the medulla oblongata (mo) (I). miR-370 expression
signals were detected in most parts of brain, adrenal gland (ag) (J), tongue (to) (L), dorsal root ganglia (drg) (M), muscles (mu) and some bone primordium (D, E). Diverse
tissues were denoted as hindbrain (hb), optic recess (or), olfactory bulb (ob), forebrain (fb), cerebral cortex (cx), cerebellar (ce), pituitary (pi), medulla oblongata (mo),
cerebellar external granular layer (egl), forebrain ventricle zone (vz), thalamus (th), intestinal (in), olfactory epithelium (oe), vibrissae follicle (vi), osteogenic tissue (os), hind
leg (hl), temporal bone primordial (tb), bottom bone (bb), parietal bone (pc), spine (sp), segmental bronchi (sb), terminal bronchial (tb), main bronchus (mb), kidney capsular
(kc), renal medulla (mr), renal pelvis (rp), salivary glands (sg), costal cartilage (cc), nasal cavity (nc).
Fig. 5. Relative expression levels of miR-370 in diverse tissues at E15.5. The values (means ± SEM) represent the expression level relative to U6 (n = 3). Tissue types are
denoted as brain (Br), tongue (To), heart (He), lung (Lu), liver (Li), kidney (Ki), and adrenal gland (Ag).
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genes of miR-370, Dnmt3a, Dnmt3b and Itgb8were selected by pre-
dicting the potential miR-370 binding sites. Notably, Dnmt3a had
three potential recognized seeds. Further analysis involving ﬁreﬂy
luciferase reporter constructs of each target sites named pMIR-RE-
PORT-Dnmt3a-1, -Dnmt3a-2, -Dnmt3b and -Itgb8 were con-
structed (Sup. Fig. 2B). However, pMIR-REPORT Dnmt3a was the
only target to respond to miR-370 as determined by luciferase re-
porter assay.
DNMT3A is frequently mutated in many human cancers [38],
while miR-370 has been noted to be differentially expressed insome cancers, such as pancreatic cancer [39], bladder cancer
[40], renal carcinoma [41] and promyelocytic leukemia [42]. With
the exceptions of TGFb-RII [27],MAP3K8 [28], Cpt1a [23] and FoxM1
[26], miR-370 target genes remain unknown. Therefore, it is obvi-
ous that the regulation of miR-370 is more complex than antici-
pated. We further analyzed miR-370 expression in several colon
cancer cell lines in comparison with non-cancer cell lines, to fur-
ther aid understanding of its function (Sup. Fig. 1A). Given that
miR-370 targets Dnmt3a and the miR-370 knockin mice are avail-
able, the roles of miR-370 during development and in tumorigen-
esis in vivo should be determined in further studies.
Fig. 6. miR-370 directly inhibits expression of Dnmt3a. (A) Putative binding sites for mouse miR-370 in the 30UTR of Dnmt3a mRNA, seed match regions are shown in red. (B)
Endogenous Dnmt3a expression was detected by western blot in NIH3T3 and AtT20 cells. (C) The effect of miR-370 on Dnmt3a gene 30UTR-luciferase activity in the presence
or absence of miR-370 inhibitor was examined in NIH3T3 cells. (D) The effect of inhibiting endogenous miR-370 on Dnmt3a gene 30UTRL luciferase activity in AtT20 cells. (E,
F) Dnmt3a protein expression was detected by western blot to conﬁrm the targeted impact of miR-370 with (F) or without miR-370 inhibition. Data of (C) and (D) are
mean ± SEM of three independent experiments, ⁄P < 0.02; ⁄⁄P < 0.05. Data of (E) and (F) are shown as one representative experiment. Similar results were observed in three
independent experiments.
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